ABT
Stock Details
ABT is Abbott Laboratories's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 105.82$. Average daily volumn in 3 months 4.72M. Market cap 178.78B
Stock symbol : ABT. Exchange : NYSE. Currency : USD Lastest price : 102.09$. Total volume : 2.27M. Market state REGULAR Click reload if you want to check the lastest price on market!!!
Abbott Laboratories (ABT)
Last Price
102.09$Change
2.57Volume
2.27M
| Previous Close | 99.52 |
| Open | 100.74 |
| Day Range | 100.58-102.72 |
| Bid | 102.44 x 800 |
| Ask | 102.46 x 1k |
| Volume | 2.27M |
| Average Volume | 4.72M |
| Market Cap | 178.78B |
| Beta | 0.71 |
| 52 Week Range | 96.67-142.60 |
| Trailing P/E | 21.31 |
| Foward P/E | 21.86 |
| Dividend (Yield %) | 1.94% |
| Ex-Dividend Date | 2022-10-13 |
Financial Details
Organization
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecologi... cal disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Market Cap:
178.78BRevenue:
43.08BTotal Assets:
75.2BTotal Cash:
9.8B
News about "Abbott Laboratories"
ABBOTT LABORATORIES SHAREHOLDER ALERT BY FORMER...
Source from : Benzinga.com - 21 hours ago
NEW ORLEANS, LA / ACCESSWIRE / October 3, 2022 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until Octob ...See details»
There's Reason For Concern Over Abbott Laboratories' (NYSE:ABT) Price
Source from : YAHOO!Finance - 1 days ago
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 13x, you ...See details»
ROSEN, A LONGSTANDING LAW FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABT
Source from : Business Insider - 6 days ago
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Abbott Laboratories (NYSE: ABT) between February 19, 2021 and June 8, 2022, both dates inclusive ...See details»
Abbott Laboratories Enters Oversold Territory
Source from : Nasdaq - 7 days ago
Abbott Laboratories (Symbol: ABT) presently has an excellent rank, in the top 25% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further research ...See details»
Abbott Laboratories Deadline Alert
Source from : MarketWatch - 9 days ago
If you suffered losses exceeding $100,000 investing in Abbott Laboratories stock or options between February 19, 2021 and June 8, 2022 and would like to discuss your legal rights, call Faruqi & Faruqi ...See details»
Abbott Laboratories (NYSE:ABT) Shares Bought by Global Retirement Partners LLC
Source from : Defense World - 8 days ago
Global Retirement Partners LLC grew its stake in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 8.5% in the 2nd quarter, according to its most recent filing with the Securities & Exchange ...See details»
December 16th Options Now Available For Abbott Laboratories (ABT)
Source from : Nasdaq - 12 days ago
Investors in Abbott Laboratories (Symbol: ABT) saw new options begin trading today, for the December 16th expiration. One of the key data points that goes into the price an option buyer is willing to ...See details»
Abbott Laboratories Target of Unusually High Options Trading (NYSE:ABT)
Source from : Defense World - 4 days ago
Abbott Laboratories (NYSE:ABT – Get Rating) was the target of some unusual options trading on Thursday. Stock investors purchased 23,539 put options on the stock. This is an increase of approximately ...See details»
Does Abbott Laboratories (NYSE:ABT) Deserve A Spot On Your Watchlist?
Source from : AOL - 13 days ago
Despite being in the age of tech-stock blue-sky investing, many investors still adopt a more traditional strategy; buying shares in profitable companies like Abbott Laboratories (NYSE:ABT).See details»
ABBOTT LABORATORIES SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF ...
Source from : The Bakersfield Californian - 6 days ago
The case is Pembroke Pines Firefighters & Police Officers Pension Fund v. Abbott Laboratories, No. 22-cv-04661. About ClaimsFiler ClaimsFiler has a single mission: to serve as the information ...See details»
ABBOTT LABORATORIES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK
Source from : Associated Press - 13 days ago
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 31, 2022 to file lead plaintiff applications ...See details»
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abbott Laboratories - ABT
Source from : Benzinga.com - 1 days ago
Pomerantz LLP is investigating claims on behalf of investors of Abbott Laboratories ("Abbott" or the "Company") (NYSE:ABT). Such investors are advised to contact ...See details»
FDA outlines flaws in how it handled formula shortage linked to Abbott recalls
Source from : Crain's Chicago Business - 13 days ago
The U.S. Food & Drug Administration is criticizing Abbott Laboratories for conditions at a factory tied to a nationwide recall of baby formula. A new FDA report said conditions it observed at ...See details»
Can Abbott’s Freestyle Libre Help Reduce Diabetes-Related Hospitalizations?
Source from : MD&M East - 11 days ago
Abbott Laboratories Freestyle Libre continuous glucose monitoring (CGM) system can help reduce diabetes-related hospitalizations; a new study shows. Data from the Real-World Evidence of Freestyle ...See details»